Grapefruit USA Inc
Grapefruit USA, Inc. operates as a manufacturer and distributor of cannabis products in California. It primarily provides Hourglass, a time release THC+CBD-infused topical cream through online store. Grapefruit USA, Inc. was formerly known as Grapefruit Boulevard Investments, Inc. and changed its name to Grapefruit USA, Inc. in January 2020. Grapefruit USA, Inc. was incorporated in 2017 and is ba… Read more
Grapefruit USA Inc (GPFT) - Net Assets
Latest net assets as of June 2025: $-7.68 Million USD
Based on the latest financial reports, Grapefruit USA Inc (GPFT) has net assets worth $-7.68 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.52 Million) and total liabilities ($9.21 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-7.68 Million |
| % of Total Assets | -504.92% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Grapefruit USA Inc - Net Assets Trend (2004–2024)
This chart illustrates how Grapefruit USA Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Grapefruit USA Inc (2004–2024)
The table below shows the annual net assets of Grapefruit USA Inc from 2004 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-8.12 Million | -17.65% |
| 2023-12-31 | $-6.90 Million | -13.36% |
| 2022-12-31 | $-6.09 Million | -4.69% |
| 2021-12-31 | $-5.81 Million | -24.25% |
| 2020-12-31 | $-4.68 Million | -5.54% |
| 2019-12-31 | $-4.43 Million | -24783.70% |
| 2019-04-30 | $-17.82K | +99.66% |
| 2018-12-31 | $-5.31 Million | -43.21% |
| 2017-12-31 | $-3.71 Million | +54.49% |
| 2016-12-31 | $-8.15 Million | -111.59% |
| 2015-12-31 | $-3.85 Million | +80.57% |
| 2011-12-31 | $-19.82 Million | -312.05% |
| 2010-12-31 | $-4.81 Million | -198.63% |
| 2009-12-31 | $-1.61 Million | +44.91% |
| 2008-12-31 | $-2.92 Million | +14.46% |
| 2007-12-31 | $-3.42 Million | -15.64% |
| 2006-12-31 | $-2.96 Million | +2.64% |
| 2005-12-31 | $-3.04 Million | -24.93% |
| 2004-12-31 | $-2.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Grapefruit USA Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1929329000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $110.67K | % |
| Other Components | $15.45 Million | % |
| Total Equity | $-8.11 Million | 100.00% |
Grapefruit USA Inc Competitors by Market Cap
The table below lists competitors of Grapefruit USA Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chapters Group AG
XETRA:CHG
|
$330.40K |
|
Polymeric Resources Corporation
PINK:PLYR
|
$330.61K |
|
PPL - Dusseldorf Stock Exchang
DU:PP9
|
$330.85K |
|
Ternium SA
STU:T5Z
|
$330.87K |
|
New Momentum Corporation
PINK:NNAX
|
$330.34K |
|
Cingulate Inc. Warrants
NASDAQ:CINGW
|
$330.18K |
|
Lanbay Inc
PINK:LNBY
|
$330.16K |
|
Syros Pharmaceuticals Inc
NASDAQ:SYRS
|
$329.84K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Grapefruit USA Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -6,893,814 to -8,111,668, a change of -1,217,854.
- Net loss of 1,218,000 reduced equity.
- Other comprehensive income increased equity by 110,671.
- Other factors decreased equity by 110,525.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.22 Million | -15.02% |
| Other Comprehensive Income | $110.67K | +1.36% |
| Other Changes | $-110.53K | -1.36% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Grapefruit USA Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | $-0.31 | $0.00 | x |
| 2005-12-31 | $-0.36 | $0.00 | x |
| 2006-12-31 | $-0.30 | $0.00 | x |
| 2007-12-31 | $-0.32 | $0.00 | x |
| 2008-12-31 | $-0.24 | $0.00 | x |
| 2009-12-31 | $-0.11 | $0.00 | x |
| 2010-12-31 | $-0.26 | $0.00 | x |
| 2011-12-31 | $-1.01 | $0.00 | x |
| 2015-12-31 | $-0.42 | $0.00 | x |
| 2016-12-31 | $-0.77 | $0.00 | x |
| 2017-12-31 | $-0.24 | $0.00 | x |
| 2018-12-31 | $-0.14 | $0.00 | x |
| 2019-12-31 | $-0.01 | $0.00 | x |
| 2020-12-31 | $-0.01 | $0.00 | x |
| 2021-12-31 | $-0.01 | $0.00 | x |
| 2022-12-31 | $-0.01 | $0.00 | x |
| 2023-12-31 | $-0.01 | $0.00 | x |
| 2024-12-31 | $-0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Grapefruit USA Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 0.00% | -149.65% | 1.22x | 0.00x | $-1.67 Million |
| 2005 | 0.00% | -58.21% | 3.72x | 0.00x | $-916.46K |
| 2006 | 0.00% | -153.10% | 2.00x | 0.00x | $-1.83 Million |
| 2007 | 0.00% | -155.66% | 4.51x | 0.00x | $-1.72 Million |
| 2008 | 0.00% | -51.65% | 3.24x | 0.00x | $-614.67K |
| 2009 | 0.00% | -140.07% | 1.14x | 0.00x | $-1.75 Million |
| 2010 | 0.00% | -356.92% | 1.98x | 0.00x | $-3.72 Million |
| 2011 | 0.00% | -1676.99% | 1.50x | 0.00x | $-15.95 Million |
| 2015 | 0.00% | 250.49% | 17.25x | 0.00x | $3.02 Million |
| 2016 | 0.00% | -20436.48% | 1.46x | 0.00x | $-5.95 Million |
| 2017 | 0.00% | 6820.63% | 11.64x | 0.00x | $3.22 Million |
| 2018 | 0.00% | -4479.29% | 12.77x | 0.00x | $-7.60 Million |
| 2019 | 0.00% | -102.04% | 0.28x | 0.00x | $-520.75K |
| 2019 | 0.00% | -1021.51% | 0.16x | 0.00x | $-4.17 Million |
| 2020 | 0.00% | -110.48% | 1.20x | 0.00x | $-3.59 Million |
| 2021 | 0.00% | -934.70% | 0.21x | 0.00x | $-4.92 Million |
| 2022 | 0.00% | -9493.29% | 0.02x | 0.00x | $-3.17 Million |
| 2023 | 0.00% | -925000.00% | 0.00x | 0.00x | $-1.16 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-406.83K |
Industry Comparison
This section compares Grapefruit USA Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Grapefruit USA Inc (GPFT) | $-7.68 Million | 0.00% | N/A | $330.36K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |